FDA Cracks Down on Counterfeit Ozempic Amidst Soaring Demand
TL;DR Summary
The US Food and Drug Administration (FDA) has seized "thousands of units" of counterfeit Ozempic, a drug manufactured by Novo Nordisk, due to high demand. The FDA warned patients to check their product and discard it if labeled with the lot number NAR0074 and serial number 430834149057. The counterfeit Ozempic has caused five reported cases of illness, although none were serious. The fake product includes faulty needles, posing an increased risk of infection. Novo Nordisk is working with the FDA to test the seized products. Ozempic, originally designed to treat Type 2 diabetes, has gained popularity for its weight-loss effects.
- FDA seizes 'thousands of units' of fake Ozempic as demand soars New York Post
- FDA warns of counterfeit Ozempic being sold in salons, on social media WKRC TV Cincinnati
- Fake Ozempic Seized by FDA as Demand for Obesity Drugs Soars Bloomberg
- Beware of Illegally Marketed Diabetes Treatments, Fraudulent Pharmacie FDA.gov
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
85%
663 → 100 words
Want the full story? Read the original article
Read on New York Post